Company Overview | Founders | Contact

Medilyzer™ is the first user-driven OTC drug information system specifically designed to reduce the health risks associated with OTC products.

Medilyzer™ launched in 2008 under the direction of A. Mizan Rahman, the founder and CEO. Faced with confusion when seeking to purchase medicine for his young daughter, Rahman recognized the struggle all parents must experience when trying to provide their children with safe medications. Realizing that hundreds of thousands of both adults and children are admitted to emergency facilities each year due to preventable adverse drug interactions, Medilyzer™ was established.

Based upon the philosophy of problem solving, Medilyzer™ is dedicated to saving lives, reducing healthcare costs, and improving the consumer shopping experience. Medilyzer™ seeks to close the tremendous gap between consumer knowledge and OTC drug risk information by providing consumers with a multi-lingual OTC drug counseling solution.

Medilyzer™ helps consumers to better understand the risks associated with OTC products and make more informed purchasing decisions, without having to involve a pharmacist. Simultaneously, a unique customer experience is provided resulting in improved sales and increased store loyalty.
There are four unique ways to utilize the Medilyzer™ solution:

Medilyzer™ MedPortal - a powerful 24 hour information portal for medical professionals
Medilyzer™ Smart Panel – an easy to use, comprehensive consumer touch-screen kiosk
Medilyzer™ Smart Phone Applications – mobile OTC drug risk processing software
Medilyzer™ Web Service Portal – a web user informational database

Each of these elements provides comprehensive, interactive OTC drug information to both consumers and medical professionals.
Medilyzer™ is a spinoff innovation of M2SYS Technology, a recognized industry leader in biometric technology. M2SYS is a global biometric research and development firm founded in 2002.